General Information of This Antibody-drug Conjugate (ID: DRG0GRGXW)
ADC Name
C-ADC
Drug Status
Investigative
Drug-to-Antibody Ratio
3.91
Structure
Antibody Name
Trastuzumab
 Antibody Info 
Antigen Name
Receptor tyrosine-protein kinase erbB-2 (HER2)
 Antigen Info 
Payload Name
Monomethyl auristatin E
 Payload Info 
Payload Target
Microtubule (MT)
 Target Info 
Linker Name
Divinylpyrimidine-PEG4-Val-Ala-PABC
 Linker Info 
Conjugate Type
Reduction of the 4 interchain disulfides in a IgG1 is followed by treatment with a thiol-selective bis-reactive linker that can covalently cross-link the reduced cysteines.